These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32391379)
1. Clinical Significance of an m6A Reader Gene, Deng X; Jiang Q; Liu Z; Chen W Front Mol Biosci; 2020; 7():68. PubMed ID: 32391379 [TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
3. Molecular Characteristics, Prognostic Value, and Immune Characteristics of m Geng X; Zhang Y; Zeng Z; Zhu Z; Wang H; Yu W; Li Q Front Oncol; 2021; 11():629718. PubMed ID: 33816266 [TBL] [Abstract][Full Text] [Related]
4. Identification of Two m6A Readers Li S; Wu Q; Liu J; Zhong Y Front Genet; 2022; 13():903634. PubMed ID: 35646049 [No Abstract] [Full Text] [Related]
5. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
6. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma. Hu Y; Chen J; Liu M; Feng Q; Peng H Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789 [TBL] [Abstract][Full Text] [Related]
7. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. Paramasivam A; George R; Priyadharsini JV Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868 [TBL] [Abstract][Full Text] [Related]
8. IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway. Yu D; Xiao Z; Zou Z; Lin L; Li J; Tan J; Chen W Front Oncol; 2023; 13():1252999. PubMed ID: 37936610 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Investigation of m6A Regulators for Prognosis in Head and Neck Squamous Cell Carcinoma. Cheng J; Lyu Y; Cheng Z J Environ Pathol Toxicol Oncol; 2024; 43(1):45-60. PubMed ID: 37824369 [TBL] [Abstract][Full Text] [Related]
10. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma. Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991 [TBL] [Abstract][Full Text] [Related]
11. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA. Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979 [TBL] [Abstract][Full Text] [Related]
12. Construction and clinical evaluation of N6-methyladenosine risk signature of YTHDC2, IGF2BP2, and HNRNPC in head and neck squamous cell carcinoma. Yue Q; Xu L; Zhang D Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Dec; 40(6):704-709. PubMed ID: 36416324 [TBL] [Abstract][Full Text] [Related]
13. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma. Arumugam P; George R; Jayaseelan VP Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437 [TBL] [Abstract][Full Text] [Related]
14. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma. Wang X; Xu H; Zhou Z; Guo S; Chen R Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma. Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S Front Oncol; 2020; 10():718. PubMed ID: 32547941 [TBL] [Abstract][Full Text] [Related]
16. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma. Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483 [TBL] [Abstract][Full Text] [Related]
17. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253 [TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma. Cai H; Liang J; Jiang Y; Tan R; Hou C; Hou J Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230580 [TBL] [Abstract][Full Text] [Related]
19. The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications. Cen WN; Pang JS; Huang JC; Hou JY; Bao WG; He RQ; Ma J; Peng ZG; Hu XH; Ma FC Pathol Res Pract; 2018 Nov; 214(11):1835-1847. PubMed ID: 30243807 [TBL] [Abstract][Full Text] [Related]
20. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Wang J; Chen L; Qiang P Cancer Cell Int; 2021 Feb; 21(1):99. PubMed ID: 33568150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]